Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04053075 · ClinicalTrials.gov registry record · NA
CLUSTER Trial for Outbreak Detection and Response
A NA study of Cluster Detection, sponsored by Harvard Pilgrim Health Care.
- Completed
- Registry status
- NA
- Development phase
- 2,905,455
- Enrollment target
- 20
- Study locations
NCT04053075 is a NA study of Cluster Detection that has completed, run by Harvard Pilgrim Health Care. The registered enrollment target is 2,905,455 participants. The trial reports 20 study locations across 3 states.
The verdict
NCT04053075, a NA study of Cluster Detection, has completed, sponsored by Harvard Pilgrim Health Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,905,455 participants
- Enrollment target
- 20
- Study locations
Study Summary
Despite the critical importance of identifying hospital-associated outbreaks as early as possible in order to limit their spread, there are currently no standardized methods for cluster detection. The CLUSTER Trial (Cluster Linkage Using Statistics to Trigger and Evaluate Response) will assess whether a statistically-based automated cluster detection method coupled with a robust response protocol will enable rapid containment of hospital clusters as measured by a reduction in cluster size and duration as compared to routine hospital cluster detection methods coupled with the same response protocol. Note: that enrolled "subjects" represents 82 individual HCA Healthcare hospitals that have been randomized
Conditions Studied
Interventions
- OTHER Routine cluster detection
- OTHER Enhanced cluster detection
Study Locations (20)
Florida
- JFK Medical Center - Atlantis
- Brandon Regional - Brandon
- Lawnwood Regional Medical Center - Ft. Pierce
- Memorial Hospital Jacksonville - Jacksonville
- Lake City Medical Center - Lake City
- Largo Medical Center - Largo
- Ocala Regional Medical Center - Ocala
- West Marion Community Hospital - Ocala
- Raulerson Hospital - Okeechobee
- Orange Park Medical Center - Orange Park
- Gulf Coast Medical Center - Panama City
- West Florida Hospital - Pensacola
Colorado
- Swedish Medical Center - Denver
- Sky Ridge Medical Center - Denver
- Presbyterian St. Luke's Medical Center - Denver
- Rose Medical Center - Denver
- North Suburban Medical Center - JV - Thornton
California
- Riverside Community Hospital - Riverside
- Regional Medical Center of San Jose - San Jose
- Los Robles Regional Medical Center - Thousand Oaks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,905,455 participants |
| Start Date | 2019-07-23 |
| Est. Completion | 2024-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04053075
The ClinicalTrials.gov registry entry for NCT04053075 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,905,455 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Harvard Pilgrim Health Care, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cluster Detection appearing as the primary indexed condition, and to 2 interventions - of which Routine cluster detection is the first listed.
NCT04053075 reports 20 study locations spanning 3 distinct geographic areas - top geographies include Florida, Colorado, California.
Frequently Asked Questions
What is clinical trial NCT04053075 about?
NCT04053075 is a clinical study titled "CLUSTER Trial for Outbreak Detection and Response". Despite the critical importance of identifying hospital-associated outbreaks as early as possible in order to limit their spread, there are currently no standardized methods for cluster detection. The CLUSTER Trial (Cluster Linkage Using Statistics to Trigger and Evaluate Response) will assess wheth...
What is the current status of trial NCT04053075?
This trial is currently completed. It is a NA study. The enrollment target is 2,905,455 participants. The study started on 2019-07-23. Estimated completion is 2024-05-20.
What conditions does trial NCT04053075 study?
This clinical trial studies the following conditions: Cluster Detection.
What interventions are being tested in trial NCT04053075?
The interventions under investigation include: Routine cluster detection (OTHER), Enhanced cluster detection (OTHER).
Who is sponsoring clinical trial NCT04053075?
This trial is sponsored by Harvard Pilgrim Health Care, which has 28 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04053075 being conducted?
This trial has 20 study locations across California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.